Report Detail
Global DNA Vaccines Market Insights, Forecast to 2025
- RnM3109110 |
- 12 March, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
North America is the largest consumption place, with a revenue market share nearly 58% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 28% in 2017. Asia-Pacific is also an important sales area, especially in China.
The global DNA Vaccines market is valued at 3690 million US$ in 2018 and will reach 6200 million US$ by the end of 2025, growing at a CAGR of 7.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the DNA Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of DNA Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of DNA Vaccines in these regions.
This research report categorizes the global DNA Vaccines market by top players/brands, region, type and end user. This report also studies the global DNA Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Market size by Product
Recombinant Protein Vaccine
Gene-Based Vaccine
Market size by End User
Human
Animal
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global DNA Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of DNA Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global DNA Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of DNA Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of DNA Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of DNA Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 DNA Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global DNA Vaccines Market Size Growth Rate by Product
- 1.4.2 Recombinant Protein Vaccine
- 1.4.3 Gene-Based Vaccine
- 1.5 Market by End User
- 1.5.1 Global DNA Vaccines Market Size Growth Rate by End User
- 1.5.2 Human
- 1.5.3 Animal
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global DNA Vaccines Market Size
- 2.1.1 Global DNA Vaccines Revenue 2014-2025
- 2.1.2 Global DNA Vaccines Sales 2014-2025
- 2.2 DNA Vaccines Growth Rate by Regions
- 2.2.1 Global DNA Vaccines Sales by Regions
- 2.2.2 Global DNA Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 DNA Vaccines Sales by Manufacturers
- 3.1.1 DNA Vaccines Sales by Manufacturers
- 3.1.2 DNA Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global DNA Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 DNA Vaccines Revenue by Manufacturers
- 3.2.1 DNA Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 DNA Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 DNA Vaccines Price by Manufacturers
- 3.4 DNA Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 DNA Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers DNA Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into DNA Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global DNA Vaccines Sales by Product
- 4.2 Global DNA Vaccines Revenue by Product
- 4.3 DNA Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global DNA Vaccines Breakdown Data by End User
6 North America
- 6.1 North America DNA Vaccines by Countries
- 6.1.1 North America DNA Vaccines Sales by Countries
- 6.1.2 North America DNA Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America DNA Vaccines by Product
- 6.3 North America DNA Vaccines by End User
7 Europe
- 7.1 Europe DNA Vaccines by Countries
- 7.1.1 Europe DNA Vaccines Sales by Countries
- 7.1.2 Europe DNA Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe DNA Vaccines by Product
- 7.3 Europe DNA Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific DNA Vaccines by Countries
- 8.1.1 Asia Pacific DNA Vaccines Sales by Countries
- 8.1.2 Asia Pacific DNA Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific DNA Vaccines by Product
- 8.3 Asia Pacific DNA Vaccines by End User
9 Central & South America
- 9.1 Central & South America DNA Vaccines by Countries
- 9.1.1 Central & South America DNA Vaccines Sales by Countries
- 9.1.2 Central & South America DNA Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America DNA Vaccines by Product
- 9.3 Central & South America DNA Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa DNA Vaccines by Countries
- 10.1.1 Middle East and Africa DNA Vaccines Sales by Countries
- 10.1.2 Middle East and Africa DNA Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa DNA Vaccines by Product
- 10.3 Middle East and Africa DNA Vaccines by End User
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck DNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck DNA Vaccines Products Offered
- 11.1.5 Merck Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK DNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK DNA Vaccines Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Sanofi
- 11.3.1 Sanofi Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi DNA Vaccines Products Offered
- 11.3.5 Sanofi Recent Development
- 11.4 Zoties
- 11.4.1 Zoties Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Zoties DNA Vaccines Products Offered
- 11.4.5 Zoties Recent Development
- 11.5 Elanco
- 11.5.1 Elanco Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Elanco DNA Vaccines Products Offered
- 11.5.5 Elanco Recent Development
- 11.6 Boehringer-Ingelheim
- 11.6.1 Boehringer-Ingelheim Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Boehringer-Ingelheim DNA Vaccines Products Offered
- 11.6.5 Boehringer-Ingelheim Recent Development
- 11.7 Indian Immunologicals
- 11.7.1 Indian Immunologicals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Indian Immunologicals DNA Vaccines Products Offered
- 11.7.5 Indian Immunologicals Recent Development
- 11.8 Plumbline Life Sciences
- 11.8.1 Plumbline Life Sciences Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Plumbline Life Sciences DNA Vaccines Products Offered
- 11.8.5 Plumbline Life Sciences Recent Development
12 Future Forecast
- 12.1 DNA Vaccines Market Forecast by Regions
- 12.1.1 Global DNA Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global DNA Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 DNA Vaccines Market Forecast by Product
- 12.2.1 Global DNA Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global DNA Vaccines Revenue Forecast by Product 2019-2025
- 12.3 DNA Vaccines Market Forecast by End User
- 12.4 North America DNA Vaccines Forecast
- 12.5 Europe DNA Vaccines Forecast
- 12.6 Asia Pacific DNA Vaccines Forecast
- 12.7 Central & South America DNA Vaccines Forecast
- 12.8 Middle East and Africa DNA Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 DNA Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on DNA Vaccines. Industry analysis & Market Report on DNA Vaccines is a syndicated market report, published as Global DNA Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of DNA Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
